Snapshot from Aug 24, 2026 at 07:00 UTC. For live data and tracking: View Live
Entity

India — Drugs Controller General of India

Tracked across 7 events · 144 articles · First seen Dec 27, 2025 · Last active Aug 21, 2026

Sentiment
10
Attention
4
Events
7
Relationships
0
Live sentiment trends, attention charts, and prominence tracking available on the Ergen Dashboard
4 20
Regulatory
Impact: The India — Drugs Controller General of India has intensified regulatory surveillance on GLP-1 weight-loss drugs to prevent unauthorized sales and misuse, issuing advisories and conducting inspections.
Mar 24, 2026 · 11 articles
0 0
Domestic
Alka Nangia Arora, a 1991-batch officer of the India — Indian Defence Accounts Service, assumed charge as the India — Drugs Controller General of India (CGDA) on August 1, 2026. With over three decades of…
Impact: The position gains a new leader, Alka Nangia Arora, who will direct defence financial management and audit functions.
Aug 01, 2026 · 6 articles
4 0
Regulatory
Impact: DCGI granted market authorization for QDENGA, marking the first dengue vaccine approval in India. This decision reflects the regulator's role in advancing public health.
Jul 20, 2026 · 93 articles
4 50
Regulatory
Pulse Pharmaceuticals, a Hyderabad-based nano pharmaceutical drug delivery company, received approval from the India — Drugs Controller General of India (DCGI) for its nano-carrier entrapped Vitamin D3 oral dispersion. The approval, announced on August 20,…
Impact: Granted regulatory approval, demonstrating its role in facilitating innovative pharmaceutical products in India.
Aug 20, 2026 · 6 articles
4 0
Domestic
Impact: The India — Drugs Controller General of India released the monthly accounts data, providing transparency on India's fiscal deficit, receipts, and expenditures.
Mar 30, 2026 · 6 articles
2 0
Regulatory
Impact: DCGI approval is awaited for resumption of Vivos' clinical trials in India and for a formal Phase I/II trial.
Jul 27, 2026 · 7 articles
4 0
Regulatory
Impact: The India — Drugs Controller General of India was informed by Indian Immunologicals Limited about the counterfeit batch of Abhayrab and is involved in the regulatory response to the issue.
Dec 27, 2025 · 15 articles
ERGEN INTELLIGENCE
Track India — Drugs Controller General of India live

Set up alerts, explore relationships, view sentiment trends, and monitor how events impact this entity in real time.

Open Dashboard

About Ergen

Ergen is a news intelligence platform that converts raw news articles into structured data. It tracks events, entities, and the relationships between them, with sentiment and attention metrics derived from thousands of articles. Pages on this site are daily static snapshots from the platform's live database. For real-time tracking, search, and alerts, the full dashboard is at app.ergen.ai.